These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
614 related articles for article (PubMed ID: 32517082)
1. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies. Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082 [TBL] [Abstract][Full Text] [Related]
2. Structure-Function Relationships in the Human P-Glycoprotein (ABCB1): Insights from Molecular Dynamics Simulations. Mora Lagares L; Pérez-Castillo Y; Minovski N; Novič M Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008783 [TBL] [Abstract][Full Text] [Related]
3. In silico study of desmosdumotin as an anticancer agent: homology modeling, docking and molecular dynamics simulation approach. Gadhe CG; Kothandan G; Cho SJ Anticancer Agents Med Chem; 2013 Dec; 13(10):1636-44. PubMed ID: 23796247 [TBL] [Abstract][Full Text] [Related]
4. In silico model for P-glycoprotein substrate prediction: insights from molecular dynamics and in vitro studies. Prajapati R; Singh U; Patil A; Khomane KS; Bagul P; Bansal AK; Sangamwar AT J Comput Aided Mol Des; 2013 Apr; 27(4):347-63. PubMed ID: 23612916 [TBL] [Abstract][Full Text] [Related]
5. Benzophenone Sulfonamide Derivatives as Interacting Partners and Inhibitors of Human P-glycoprotein. Farman S; Javed A; Arshia ; Khan KM; Nasir A; Khan AU; Lodhi MA; Gul H; Khan F; Asad M; Parveen Z Anticancer Agents Med Chem; 2020; 20(14):1739-1751. PubMed ID: 32416700 [TBL] [Abstract][Full Text] [Related]
6. Grid-independent Descriptors (GRIND) Analysis and SAR Guided Molecular Docking Studies to Probe Selectivity Profiles of Inhibitors of Multidrug Resistance Transporters ABCB1 and ABCG2. Shafi T; Jabeen I Curr Cancer Drug Targets; 2017; 17(2):177-190. PubMed ID: 27585695 [TBL] [Abstract][Full Text] [Related]
7. In Silico Prediction of P-glycoprotein Binding: Insights from Molecular Docking Studies. Vilar S; Sobarzo-Sánchez E; Uriarte E Curr Med Chem; 2019; 26(10):1746-1760. PubMed ID: 29189117 [TBL] [Abstract][Full Text] [Related]
8. Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer. Mohana S; Ganesan M; Agilan B; Karthikeyan R; Srithar G; Beaulah Mary R; Ananthakrishnan D; Velmurugan D; Rajendra Prasad N; Ambudkar SV Mol Biosyst; 2016 Jul; 12(8):2458-70. PubMed ID: 27216424 [TBL] [Abstract][Full Text] [Related]
9. Modeling drug-drug interactions of AZD1208 with Vincristine and Daunorubicin on ligand-extrusion binding TMD-domains of multidrug resistance P-glycoprotein (ABCB1). Marques MB; de Oliveira PV; Fagan SB; Oliveira BR; da Silva Nornberg BF; Almeida DV; Marins LF; González-Durruthy M Toxicology; 2019 Jan; 411():81-92. PubMed ID: 30339824 [TBL] [Abstract][Full Text] [Related]
11. Catalytic transitions in the human MDR1 P-glycoprotein drug binding sites. Wise JG Biochemistry; 2012 Jun; 51(25):5125-41. PubMed ID: 22647192 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in silico evaluation of P-glycoprotein inhibition through Hosseini Balef SS; Piramoon M; Hosseinimehr SJ; Irannejad H Chem Biol Drug Des; 2019 Mar; 93(3):283-289. PubMed ID: 30270513 [TBL] [Abstract][Full Text] [Related]
13. Study on reversal of ABCB1 mediated multidrug resistance in Colon cancer by acetogenins: An Jeevitha Priya M; Vidyalakshmi S; Rajeswari M J Biomol Struct Dyn; 2022 Jun; 40(9):4273-4284. PubMed ID: 33280531 [TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy. Breier A; Barancík M; Sulová Z; Uhrík B Curr Cancer Drug Targets; 2005 Sep; 5(6):457-68. PubMed ID: 16178819 [TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulation and molecular docking studies of 1,4-Dihydropyridines as P-glycoprotein's allosteric inhibitors. Shahraki O; Zargari F; Edraki N; Khoshneviszadeh M; Firuzi O; Miri R J Biomol Struct Dyn; 2018 Jan; 36(1):112-125. PubMed ID: 27981890 [TBL] [Abstract][Full Text] [Related]
16. Theoretical insights on helix repacking as the origin of P-glycoprotein promiscuity. Bonito CA; Ferreira RJ; Ferreira MU; Gillet JP; Cordeiro MNDS; Dos Santos DJVA Sci Rep; 2020 Jun; 10(1):9823. PubMed ID: 32555203 [TBL] [Abstract][Full Text] [Related]
17. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522 [TBL] [Abstract][Full Text] [Related]
18. Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1). He SM; Li R; Kanwar JR; Zhou SF Curr Med Chem; 2011; 18(3):439-81. PubMed ID: 21143116 [TBL] [Abstract][Full Text] [Related]
19. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046 [TBL] [Abstract][Full Text] [Related]
20. Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells. Dinić J; Podolski-Renić A; Jovanović M; Musso L; Tsakovska I; Pajeva I; Dallavalle S; Pešić M Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]